MB Levis & Associates LLC trimmed its stake in JPMorgan Chase & Co. by 13.1% during the third quarter, selling 1,867 shares and ending the period with 12,373 shares. The disposition reduced the fund’s allocation to JPMorgan to 1.7% of its portfolio, making it the firm’s 15th largest holding. As of the end of the reporting period, the remaining position was valued at $3.903 million, reflecting the firm’s ongoing portfolio rebalancing efforts away from large-cap financial names.

In the same period, IFM Investors Pty Ltd cut its JPMorgan stake by 0.5%, offloading 2,585 shares to retain 533,538 shares as of the latest 13F filing. This position represents 1.5% of IFM’s overall holdings and ranks as its tenth largest equity stake. The retained shares carried a valuation of $168.63 million at quarter end, underlining IFM’s commitment to maintaining a core allocation to the banking giant despite broader market volatility.

Analyst coverage of JPMorgan Chase & Co. shows a split outlook: 15 firms maintain a Buy rating, nine assign a Hold and three recommend Sell. Consensus price targets average $329.19, reflecting modest upside potential from current levels. Recent adjustments include upward revisions by Barclays (target raised to $342), TD Cowen (to $375) and Wolfe Research (to $346), while Deutsche Bank lowered its conviction to a Hold rating despite boosting its target to $320. This mixed sentiment underscores ongoing investor debate over interest rate impacts and capital markets performance.

Insider Robin Leopold sold 966 shares on November 7, reducing personal holdings by 1.63% to 58,479 shares. The trade generated proceeds of $301,314.72 and was disclosed via an SEC filing. Insider ownership remains low at 0.47%, but ongoing insider activity will be monitored for signs of confidence. Meanwhile, the board declared a quarterly dividend of $1.50 per share, payable January 31 to holders of record January 6, representing a 1.8% yield and a payout ratio near 29.7% of trailing earnings.